From the Department of Neurology (A.M., M.E.R., S.Y., K.L.F.), Warren Alpert Medical School of Brown University, Providence, RI.
Department of Neurosurgery (A.M., M.E.R.), Warren Alpert Medical School of Brown University, Providence, RI.
Stroke. 2019 Apr;50(4):992-994. doi: 10.1161/STROKEAHA.118.024660.
Background and Purpose- Protease/antiprotease imbalance is implicated in the pathogenesis of emphysema and may also lead to vessel wall weakening, aneurysm development, and rupture. However, it is unclear whether emphysema is associated with cerebral and aortic aneurysm rupture. Methods- We performed a retrospective cohort study using outpatient and inpatient claims data from 2008 to 2014 from a nationally representative sample of Medicare beneficiaries ≥66 years of age. Our predictor variable was emphysema, and our outcome was hospitalization for either aneurysmal subarachnoid hemorrhage or a ruptured aortic aneurysm. All predictors and outcomes were defined using previously reported International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code algorithms. Survival statistics and Cox regression were used to compare risk between patients with and without emphysema. Results- We identified 1 670 915 patients, of whom 133 972 had a diagnosis of emphysema. During a mean follow-up period of 4.3 (±1.9) years, we identified 4835 cases of aneurysm rupture, 433 of which occurred in patients with emphysema. The annual incidence of aneurysm rupture was 6.5 (95% CI, 6.4-6.8) per 10 000 in patients without emphysema and 14.6 (95% CI, 13.3-16.0) per 10 000 in patients with emphysema. After adjustment for demographics and known risk factors for aneurysmal disease, emphysema was independently associated with aneurysm rupture (hazard ratio, 1.7; 95% CI, 1.5-1.9). Emphysema was associated with both aneurysmal subarachnoid hemorrhage (hazard ratio, 1.5; 95% CI, 1.3-1.7) and ruptured aortic aneurysm (hazard ratio, 2.3; 95% CI, 1.9-2.8). Conclusions- Patients with emphysema face an increased risk of developing subarachnoid hemorrhage and aortic aneurysm rupture, potentially consistent with shared pathways in pathogenesis.
背景与目的-蛋白酶/抗蛋白酶失衡与肺气肿的发病机制有关,也可能导致血管壁减弱、动脉瘤发展和破裂。然而,目前尚不清楚肺气肿是否与脑和主动脉瘤破裂有关。方法-我们使用来自全国代表性的 Medicare 受益人群(≥66 岁)的 2008 年至 2014 年门诊和住院索赔数据进行了回顾性队列研究。我们的预测变量是肺气肿,我们的结果是蛛网膜下腔出血或主动脉瘤破裂的住院治疗。所有预测因子和结果均使用先前报道的国际疾病分类,第九版临床修正诊断代码算法进行定义。生存统计和 Cox 回归用于比较肺气肿患者和无肺气肿患者之间的风险。结果-我们确定了 1670915 名患者,其中 133972 名患者被诊断为肺气肿。在平均 4.3(±1.9)年的随访期间,我们发现了 4835 例动脉瘤破裂病例,其中 433 例发生在肺气肿患者中。无肺气肿患者的动脉瘤破裂年发生率为每 10000 人 6.5(95%CI,6.4-6.8),而肺气肿患者的年发生率为每 10000 人 14.6(95%CI,13.3-16.0)。在调整了人口统计学和已知的动脉瘤疾病危险因素后,肺气肿与动脉瘤破裂独立相关(风险比,1.7;95%CI,1.5-1.9)。肺气肿与蛛网膜下腔出血(风险比,1.5;95%CI,1.3-1.7)和破裂的主动脉瘤(风险比,2.3;95%CI,1.9-2.8)均相关。结论-肺气肿患者发生蛛网膜下腔出血和主动脉瘤破裂的风险增加,这可能与发病机制中的共同途径一致。